Wnt-induced secreted protein 1/CCN4 in liver fibrosis both in vitro and in vivo

Clinical Laboratory

Volumn 60, Issue 1, 2014, Pages 29-35

  Jian, Yi Cheng ^a   Wang, Jin Jun ^b   Dong, Shuang ^a   Hu, Jun Wei ^a   Hu, Li Juan ^a   Yang, Gen Mei ^b   Zheng, Ya Xin ^a   Xiong, Wu Jun ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Hepatic stellate cells; Liver fibrosis; TGF 1; TNF ; Wnt induced secreted protein 1

Indexed keywords

ANIMALS; BASE SEQUENCE; CARBON TETRACHLORIDE; CCN INTERCELLULAR SIGNALING PROTEINS; CELLS, CULTURED; DNA PRIMERS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893973826     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.121035     Document Type: Article

References (25)

1. Atzori L, Poli G, Perra A. Hepatic stellate cell: a star cell in the liver. Int J Biochem Cell Biol 2009;41:1639-42.
2. Li JT, Liao ZX, Ping J, Xu D, Wang H. Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J Gastroenterol 2008;43:419-28. (Pubitemid 351997878)
3. Xiong WJ, Hu LJ, Jian YC, et al. Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays. World J Gastroenterol 2012;18:1745-52.
4. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009;17:9-26.
5. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-80.
6. Bowley E, O'Gorman DB, Gan BS. Beta-catenin signaling in fibroproliferative disease. J Surg Res 2007;138:141-50.
7. Hwang I, Seo EY, Ha H. Wnt/beta-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease. Arch Pharm Res 2009;32:1653-62.
8. Cheng JH, She H, Han YP, et al. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2008;294:G39-49.
9. Myung SJ, Yoon JH, Gwak GY, et al. Wnt signaling enhances the activation and survival of human hepatic stellate cells. FEBS Lett 2007;581:2954-8. (Pubitemid 46899038)
10. Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. Hepatology 2007;45:1298-305. (Pubitemid 46775794)
11. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 2001;49:565-76. (Pubitemid 32896989)
12. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev 2000;14:585-95.
13. Su F, Overholtzer M, Besser D, Levine AJ. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev 2002;16:46-57. (Pubitemid 34049637)
14. Colston JT, de la Rosa SD, Koehler M, et al. Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor. Am J Physiol Heart Circ Physiol 2007;293:H1839-46. (Pubitemid 47367233)
15. Venkatachalam K, Venkatesan B, Valente AJ, et al. WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)- stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death. J Biol Chem 2009;284:14414-27.
16. Venkatesan B, Prabhu SD, Venkatachalam K, et al. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cell Signal 2010;22:809-20.
17. Königshoff M, Kramer M, Balsara N, et al. WNT 1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 2009;119:772-87.
18. Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006;173:188-98. (Pubitemid 43187891)
19. Gressner OA, Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 2008;28:1065-79.
20. Weiskirchen R, Gressner AM. Isolation and culture of hepatic stellate cells. Methods Mol Med 2005;117:99-113.
21. Pennica D, Swanson TA, Welsh JW, et al. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 1998;95:14717-22. (Pubitemid 29003696)
22. Shao H, Cai L, Grichnik JM, Livingstone AS, Velazquez OC, Liu ZJ. Activation of Notch 1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. Oncogene 2011;30:4316-26.
23. Bleau AM, Planque N, Perbal B. CCN proteins and cancer: two to tango. Front Biosci 2005;10:998-1009.
24. Blom AB, Brockbank SM, van Lent PL, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum 2009;60:501-12.
25. French DM, Kaul RJ, D'Souza AL, et al. WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol 2004;165:855-67. (Pubitemid 39129293)